AbCellera Biologics Inc Equity-NMS: ABCL

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$4.58
Open :	$4.42
Today's high :	$4.75
Today's low :	$4.36
52W low :	$1.8906
52W high :	$5.82
1Y :	73.99%
5Y :	-93.39%
EPS(TTM): :	-0.56
Shares O/S :	298.83 M
Market cap :	1.34 B

What is the share price of AbCellera Biologics Inc today?

AbCellera Biologics Inc (ABCL) share price as of August 15, 2025, is $4.5. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of AbCellera Biologics Inc?

Yes, Indian Investors can invest in the AbCellera Biologics Inc (ABCL) Share by opening an international trading account with Angel One.

How can I purchase AbCellera Biologics Inc shares in India?

Purchasing AbCellera Biologics Inc (ABCL) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying AbCellera Biologics Inc (ABCL) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of AbCellera Biologics Inc?

Yes, you can purchase fractional shares of AbCellera Biologics Inc (ABCL) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of AbCellera Biologics Inc?

The market capitalization of AbCellera Biologics Inc on August 15, 2025, is $1.34 B.

In which sector AbCellera Biologics Inc belongs?

AbCellera Biologics Inc operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in AbCellera Biologics Inc stocks?

In order to invest in AbCellera Biologics Inc (ABCL) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

AbCellera Biologics Inc. discovers and develops antibody medicines for indications across therapeutic areas, including cancer, metabolic and endocrine conditions, and autoimmune disorders. Its platform integrates technology, data science, infrastructure, and interdisciplinary teams to solve the challenging antibody discovery problems. It is focused on advancing an internal pipeline of programs and collaborating on drug development programs with partners. Its first two internal programs, ABCL635 and ABCL575, are in late-preclinical studies. ABCL635 is an antibody drug candidate for metabolic and endocrine conditions, and ABCL575 is an antibody drug candidate with broad potential in inflammatory conditions and autoimmune diseases and an initial indication in atopic dermatitis. ABCL575 binds OX40L to disrupt OX40/OX40L signaling, a regulator of inflammatory pathways in AD. In addition to ABCL635 and ABCL575, it is advancing a pipeline of more than 20 internal discovery programs.